ImmunoGen
IMGN
#1808
Rank
$8.72 B
Marketcap
$31.23
Share price
0.00%
Change (1 day)
719.69%
Change (1 year)

P/E ratio for ImmunoGen (IMGN)

P/E ratio as of March 2024 (TTM): -101

According to ImmunoGen 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -100.742. At the end of 2022 the company had a P/E ratio of -5.64.

P/E ratio history for ImmunoGen from 2001 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-5.64-49.11%
2021-11.1-53.64%
2020-23.9231.92%
2019-7.2081.43%
2018-3.97-36.88%
2017-6.28448.34%
2016-1.15-88.43%
2015-9.9138.02%
2014-7.18-81.9%
2013-39.6248.29%
2012-11.4-13.49%
2011-13.216.53%
2010-11.39.19%
2009-10.3119.38%
2008-4.71-55.7%
2007-10.6-5.55%
2006-11.3-20.94%
2005-14.3-79.04%
2004-68.0452.08%
2003-12.390.72%
2002-6.46-91.43%
2001-75.4

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
11.2-111.13%๐Ÿ‡บ๐Ÿ‡ธ USA
25.6-125.45%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
14.9-114.83%๐Ÿ‡บ๐Ÿ‡ธ USA
143-242.27%๐Ÿ‡บ๐Ÿ‡ธ USA
20.2-120.08%๐Ÿ‡บ๐Ÿ‡ธ USA
15.6-115.46%๐Ÿ‡ซ๐Ÿ‡ท France
13.4-113.31%๐Ÿ‡บ๐Ÿ‡ธ USA
-57.0-43.38%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.